Tocilizumab for rheumatoid and juvenile idiopathic arthritis

Tim Bongartz

doi:10.1016/S0140-6736(08)60428-6

Tocilizumab for rheumatoid and juvenile idiopathic arthritis

Tim Bongartz

Rheumatology

Research output: Contribution to journal › Comment/debate › peer-review

15 Scopus citations

Original language	English (US)
Pages (from-to)	961-963
Number of pages	3
Journal	The Lancet
Volume	371
Issue number	9617
DOIs	https://doi.org/10.1016/S0140-6736(08)60428-6
State	Published - 2008

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(08)60428-6

Cite this

@article{fc29c676b94a41dab6a0b0b517f55592,

title = "Tocilizumab for rheumatoid and juvenile idiopathic arthritis",

author = "Tim Bongartz",

year = "2008",

doi = "10.1016/S0140-6736(08)60428-6",

language = "English (US)",

volume = "371",

pages = "961--963",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9617",

}

TY - JOUR

T1 - Tocilizumab for rheumatoid and juvenile idiopathic arthritis

AU - Bongartz, Tim

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=40749155784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40749155784&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(08)60428-6

DO - 10.1016/S0140-6736(08)60428-6

M3 - Comment/debate

C2 - 18358909

AN - SCOPUS:40749155784

SN - 0140-6736

VL - 371

SP - 961

EP - 963

JO - The Lancet

JF - The Lancet

IS - 9617

ER -

Tocilizumab for rheumatoid and juvenile idiopathic arthritis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this